CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
37 hedge funds and large institutions have $15.8M invested in Crescent Biopharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 9 closing their positions.
Holders
37
Holders Change
-7
Holders Change %
-15.91%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
15
Closed
9
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
-$92K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$339K |
2 |
2
Charles Schwab
San Francisco,
California
|
$37K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.11M |
4 |
4
Millennium Management
New York
|
$260K |
5 |
5
Jane Street
New York
|
$11K |